OMDA
$14.62
Omada Health, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other suppor...
Recent News
Wall Street Analysts Believe Omada Health, Inc. (OMDA) Could Rally 59.53%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 59.5% in Omada Health, Inc. (OMDA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Could This $14 Stock Be Your Ticket to Millionaire Status?
This stock continues to benefit from GLP-1 tailwinds -- and now it trades at a reasonable valuation.
Why Omada Health (OMDA) Is Up 14.4% After First GAAP Profit And GLP-1 Flex Launch
In early March 2026, Omada Health, Inc. reported strong 2025 results with revenue of US$260.21 million, its first GAAP-profitable quarter, and issued 2026 revenue guidance of US$312 million to US$322 million alongside a US$49.57 million shelf registration for 3,644,941 common shares linked to an ESOP offering. The company also introduced GLP-1 Flex Care, a program that lets employees pay cash for obesity medications while receiving coordinated virtual care, giving employers a structured way...
Omada Health Q4 2025 Earnings Call Summary
Moby summary of Omada Health's Q4 2025 earnings call
Omada Health Q4 Earnings Call Highlights
Omada Health (NASDAQ:OMDA) reported rapid growth in 2025 and said it reached a new financial milestone in the fourth quarter, delivering its first quarter of GAAP profitability. Executives also highlighted expanding demand for its cardiometabolic platform, including GLP-1 companion care, and outline